COVID-19: the new challenge for rheumatologists
- 26 March 2020
- journal article
- editorial
- Published by Clinical and Experimental Rheumatology in Clinical and Experimental Rheumatology
- Vol. 38 (2), 175-180
- https://doi.org/10.55563/clinexprheumatol/r3k9l6
Abstract
Editorial; Authors: F. Ferro, E. Elefante, C. Baldini, E. Bartoloni, I. Puxeddu, R. Talarico, M. Mosca, S. BombardieriThis publication has 28 references indexed in Scilit:
- Lung Ultrasound for Critically Ill PatientsAmerican Journal of Respiratory and Critical Care Medicine, 2019
- Anti–spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infectionJCI Insight, 2019
- Corticosteroid therapy for sepsis: a clinical practice guidelineBMJ, 2018
- Glucocorticoid attenuates acute lung injury through induction of type 2 macrophageJournal of Translational Medicine, 2017
- Indications for IVIG in rheumatic diseasesRheumatology, 2014
- Risk of tuberculosis infection in anti-TNF-α biological therapy: From bench to bedsideJournal of Microbiology, Immunology and Infection, 2014
- Intravenous immunoglobulin-mediated immunosuppression and the development of an IVIG substituteClinical and Experimental Medicine, 2013
- Antibody responses against SARS coronavirus are correlated with disease outcome of infected individualsJournal of Medical Virology, 2005
- Severe acute respiratory syndrome: report of treatment and outcome after a major outbreakThorax, 2004
- Plasma inflammatory cytokines and chemokines in severe acute respiratory syndromeClinical and Experimental Immunology, 2004